LBF20406AM40: Difference between revisions

Latest revision as of 04:50, 21 October 2010

Upper classes: LB LBF

N- 2-Fluoroethylarachidonoylamide

Structural Information
	N- 2-Fluoroethyl- (cis-5,cis-8,cis-11,cis-14) -eicosatetraenoylamine
	N- 2-Fluoroethylarachidonoylamide N- 2-Fluoroethyl- (5Z,8Z,11Z,14Z) -eicosatetraenoylamine

Formula	C22H36FNO
Exact Mass	349.27809297899995
Average Mass	349.5257832
SMILES	`C(CF)NC(=O)CCCC=CCC=CCC=CCC=CCCCCC`
Physicochemical Information







	This compound was synthesized from arachidonoylchloride and 2-fluoroethylamine. Adams_IB et al.

	Adams_IB et al.


Spectral Information
Mass Spectra
UV Spectra
IR Spectra
NMR Spectra
Other Spectra
Chromatograms

Reported Metabolites, References

Biospecies	ID	Compound Name	Reference	Comment
n.a.	LBF20406AM40	See above.	Adams_IB et al. 1995

@@ Line 1: / Line 1: @@
+{{Lipid/Header}}
 {{Hierarchy|{{PAGENAME}}}}
@@ Line 4: / Line 6: @@
 |LipidBank=XPR7069
 |LipidMaps=LMFA08020055
-|SysName=arachidonoyl- (2'-fluoroethyl) amide
+|SysName=N- 2-Fluoroethyl- (cis-5,cis-8,cis-11,cis-14) -eicosatetraenoylamine
-|Common Name=&&arachidonoyl- (2'-fluoroethyl) amide&&
+|Common Name=&&N- 2-Fluoroethylarachidonoylamide&&N- 2-Fluoroethyl- (5Z,8Z,11Z,14Z) -eicosatetraenoylamine&&
+|Source=
+|Chemical Synthesis=This compound was synthesized from arachidonoylchloride and 2-fluoroethylamine. [[Reference:Adams_IB:Ryan_W:Singer_M:Thomas_BF:Compton_DR:Razdan_RK:Martin_BR:,J. Pharmacol. Exp. Ther.,1995,273,1172|{{RelationTable/GetFirstAuthor|Reference:Adams_IB:Ryan_W:Singer_M:Thomas_BF:Compton_DR:Razdan_RK:Martin_BR:,J. Pharmacol. Exp. Ther.,1995,273,1172}}]]
+|Metabolism=
+|Biological Activity={{Image200|LBF20406AM40FT7069.gif}} [[Reference:Adams_IB:Ryan_W:Singer_M:Thomas_BF:Compton_DR:Razdan_RK:Martin_BR:,J. Pharmacol. Exp. Ther.,1995,273,1172|{{RelationTable/GetFirstAuthor|Reference:Adams_IB:Ryan_W:Singer_M:Thomas_BF:Compton_DR:Razdan_RK:Martin_BR:,J. Pharmacol. Exp. Ther.,1995,273,1172}}]]
 }}
+{{Lipid/Footer}}